![](/img/cover-not-exists.png)
Planned safety analysis of the ACTS-CC 02 trial: A randomized phase III trial of S-1 plus oxaliplatin (SOX) versus tegafur–uracil plus leucovorin as adjuvant chemotherapy for high-risk stage III colon cancer
Kusumoto, Tetsuya, Sunami, Eiji, Ota, Mitsuyoshi, Yoshida, Kazuhiro, Sakamoto, Yoshiyuki, Tomita, Naohiro, Atsuyuki, Maeda, Mochizuki, Izumi, Okabe, Michio, Kunieda, Katsuyuki, Yamauchi, Junichiro, ItLanguage:
english
Journal:
Clinical Colorectal Cancer
DOI:
10.1016/j.clcc.2017.10.015
Date:
November, 2017
File:
PDF, 963 KB
english, 2017